CHOP reaches a major milestone in pediatric cancer treatments, treating its 500th patient with CAR T-cell immunotherapy. This and more in our weekly research news roundup.
Combining extraordinary care, innovative translational research, and novel innovations to improve outcomes for children with common and complex airway disorders.
